A number of therapeutic decisions need to be made for a infant or child with community-acquired pneumonia (CAP). These are often influenced by a number of clinical factors. The authors are from the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.
Patient selection: infant > 3 months old, child
Factor |
Impact |
---|---|
age in years |
young infants often have viral infections, especially if immunized |
immunization status |
more aggressive management required if not fully immunized |
outpatient vs inpatient vs life-threatening |
an outpatient can often be managed with oral therapy, while an inpatient often requires parenteral therapy |
MRSA possible |
addition of vancomycin or clindamycin |
in a region with penicillin resistant Streptococcus pneumoniae |
therapy with third generation cephalosporin (below) |
other Streptococcus pneumoniae |
may be resistant to macrolides |
influenza |
therapy with agents active against influenza can be beneficial, secondary bacterial infection may require antibiotic therapy, negative rapid test does not exclude the diagnosis |
other virus |
antibiotics not indicated unless secondary bacterial infection occurs |
atypical bacteria |
macrolide antibiotic |
allergy to first-line therapy |
select alternative agent or desensitize |
failure of initial therapy |
need to know pathogen and antibiotic susceptibility; confirm compliance, antibiotic dosing and kinetics |
recurrent CAP |
consider evaluation for immunodeficiency or a foreign body |
A penicillin (ampicillin for parenteral inpatient therapy, amoxicillin for oral outpatient) is often a starting point for therapy if:
(1) the patient is fully-immunized
(2) penicillin-resistant Streptococcus pneumoniae is not an issue
(3) there are not other factors (see above) influencing the decision
Indications for therapy with a parenteral third generation cephalosporin (ceftriazone, cefotaxime, other):
(1) not fully immunized
(2) in a region with penicillin-resistant Streptococcus pneumoniae
(3) life-threatening infection (often in the ICU, may have empyema)
Purpose: To identify factors affecting the choice of therapy for a pediatric patient with community-acquired pneumonia (CAP).
Specialty: Infectious Diseases, Pharmacology, clinical, Pulmonology
Objective: options, selection, drug interactions
ICD-10: J13, J14, J15, J18,